MAPT and Alzheimer disease: While there is good evidence indicating that plasma measures of tau and Aβ are indicative of CNS levels and corresponding AD pathologies, they do not exclusively reflect central production of these proteins and therefore may also reflect processes unrelated to AD pathology.